Review: The Diabetic Bone: A Cellular and Molecular Perspective
- 28 March 2011
- journal article
- review article
- Published by SAGE Publications in The International Journal of Lower Extremity Wounds
- Vol. 10 (1), 16-32
- https://doi.org/10.1177/1534734611400256
Abstract
With the increasing worldwide prevalence of diabetes the resulting complications, their consequences and treatment will lead to a greater social and financial burden on society. One of the many organs to be affected is bone. Loss of bone is observed in type 1 diabetes, in extreme cases mirroring osteoporosis, thus a greater risk of fracture. In the case of type 2 diabetes, both a loss and an increase of bone has been observed, although in both cases the quality of the bone overall was poorer, again leading to a greater risk of fracture. Once a fracture has occurred, healing is delayed in diabetes, including nonunion. The reasons leading to such changes in the state of the bone and fracture healing in diabetes is under investigation, including at the cellular and the molecular levels. In comparison with our knowledge of events in normal bone homeostasis and fracture healing, that for diabetes is much more limited, particularly in patients. However, progress is being made, especially with the use of animal models for both diabetes types. Identifying the molecular and cellular changes in the bone in diabetes and understanding how they arise will allow for targeted intervention to improve diabetic bone, thus helping to counter conditions such as Charcot foot as well as preventing fracture and accelerating healing when a fracture does occur.Keywords
This publication has 226 references indexed in Scilit:
- Malfunction of bone marrow-derived osteoclasts and the delay of bone fracture healing in diabetic miceBone, 2010
- TNF-α mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis Through FOXO1Journal of Bone and Mineral Research, 2010
- Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1Bone, 2010
- HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineageBone, 2010
- Growth factor control of bone massJournal of Cellular Biochemistry, 2009
- Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatmentBone, 2009
- High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesisBone, 2008
- Molecular and cellular mechanisms of the anabolic effect of intermittent PTHBone, 2007
- Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathwaysBone, 2007
- Characterization and function of the receptor for IGF-I in human preosteoclastic cellsBone, 1996